“…For example, the cost per vaccine dose tends to be a key parameter in economic evaluations, and these studies utilized values that may not be comparable-ranging from $0.60 to $5 per dose, while in others it was calculated based on program costs for vaccination campaigns. While these studies had several strengths (e.g., evaluated relevant populations, 43,44,46 large populations/sample size, 46 included appropriate costs and factors impacting vaccination and costs, 43,44,46 performed sensitivity analysis, 44 explored various realistic scenarios, 44 and had appropriate cost inclusions 44 ), limitations include interviews and questionnaires to gather costs (which may incur recall bias), 43,44 no probabilistic sensitivity analysis were performed in one study, 43 and the effects of waning immunity were not considered (although this most likely would have a little effect). 43,44 Additionally, herd protection is location specific, and with limited data, assumptions were made.…”